D

Dr.Umesh Laddi's Med-Chemist

Do regularly update on FDA approvals, clinical trials, new
drugs, side effects, drug discovery, synthetic chemistry,
med, chemist,

  • Rated2.5/ 5
  • Updated 1 Year Ago

FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

Updated 1 Year Ago